T-cell regulation by CD28 and CTLA-4 (original) (raw)

• Bretscher, P. & Cohn, M. A theory of self–nonself discrimination. Science 169, 1042–1049 (1970).
  CAS PubMed Google Scholar
• Lafferty, K. J. & Cunningham, A. J. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53, 27–42 (1975).
  CAS PubMed Google Scholar
• Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. & Eisen, H. N. Evidence that a single peptide–MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565–571 (1996).
  CAS PubMed Google Scholar
• Valitutti, S., Muller, S., Cella, M., Padovan, E. & Lanzavecchia, A. Serial triggering of many T-cell receptors by a few peptide–MHC complexes. Nature 375, 148–151 (1995).
  CAS PubMed Google Scholar
• Davis, M. M. et al. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16, 523–544 (1998).
  CAS PubMed Google Scholar
• Kersh, G. J., Kersh, E. N., Fremont, D. H. & Allen, P. M. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9, 817–826 (1998).
  CAS PubMed Google Scholar
• Kalergis, A. M. et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nature Immunol. 2, 229–234 (2001). Mutations in the antigen-binding site of the TCR that significantly decrease or increase the half-life of the association between TCR with MHC–peptide complex were shown to result in impaired T-cell activation, indicating an optimal interaction time.
  CAS Google Scholar
• Lanzavecchia, A. & Sallusto, F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nature Immunol. 2, 487–492 (2001).
  CAS Google Scholar
• Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89–95 (1998).
  Article CAS PubMed Google Scholar
• Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258 (1996).
  CAS PubMed Google Scholar
• Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G. & Thompson, C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244, 339–343 (1989).
  CAS Google Scholar
• Boise, L. H. et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597–608 (1993).
  CAS PubMed Google Scholar
• Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W. & Bluestone, J. A. CD28 costimulation promotes the production of TH2 cytokines. J. Immunol. 158, 658–665 (1997).
  CAS PubMed Google Scholar
• Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104–106 (1996).
  CAS PubMed Google Scholar
• Itoh, Y. & Germain, R. N. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells. J. Exp. Med. 186, 757–766 (1997).
  CAS PubMed PubMed Central Google Scholar
• Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680–682 (1999).
  Article CAS PubMed Google Scholar
• Raab, M. et al. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl Acad. Sci. USA 92, 8891–8895 (1995).
  CAS PubMed PubMed Central Google Scholar
• King, P. D. et al. Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J. Immunol. 158, 580–590 (1997).
  CAS PubMed Google Scholar
• Pages, F. et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369, 327–329 (1994).
  CAS PubMed Google Scholar
• Prasad, K. V. et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)–Met–Xaa–Met motif. Proc. Natl Acad. Sci. USA 91, 2834–2388 (1994).
  CAS PubMed PubMed Central Google Scholar
• Schneider, H., Cai, Y. C., Prasad, K. V., Shoelson, S. E. & Rudd, C. E. T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras. Eur. J. Immunol. 25, 1044–1050 (1995).
  CAS PubMed Google Scholar
• Chuang, E. et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13, 313–322 (2000). Shows that both CD28 and CTLA-4 can associate with the serine/threonine phosphatase PP2A and indicates that PP2A might negatively regulate T-cell activation.
  CAS PubMed Google Scholar
• Cefai, D. et al. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J. Immunol. 160, 2223–2230 (1998).
  CAS PubMed Google Scholar
• Shan, X. et al. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20, 6945–6957. (2000).
  CAS PubMed PubMed Central Google Scholar
• Truitt, K. E. et al. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155, 4702–4710 (1995).
  CAS PubMed Google Scholar
• Crooks, M. E. et al. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell. Biol. 15, 6820–6828 (1995).
  CAS PubMed PubMed Central Google Scholar
• Harada, Y. et al. Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation. J. Biol. Chem. 276, 9003–9008 (2001).
  CAS PubMed Google Scholar
• Cai, Y. et al. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86–CD28-mediated costimulation. Immunity 3, 417–426 (1995).
  CAS PubMed Google Scholar
• Okkenhaug, K. et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nature Immunol. 2, 325–332 (2001).Experiments performed using T cells from CD28-deficient mice reconstituted with CD28 mutants indicate that a mutation on Y170 that abolishes its association with both PI3K and Grb2 prevents CD28-mediated increase in Bcl-x L expression, but does not affect cytokine production or proliferation.
  CAS Google Scholar
• Harada, Y. et al. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166, 3797–3803 (2001).
  CAS PubMed Google Scholar
• Burr, J. S. et al. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-xL . J. Immunol. 166, 5331–5335 (2001).Experiments performed using CD28-deficient T cells reconstituted by retroviral transduction with mutants of CD28 indicate that phosphorylation of Y170 might promote upregulation of Bcl-x L , whereas the C-terminal P-rich region might control IL–2 production and proliferation.
  CAS PubMed Google Scholar
• Kane, L. P., Andres, P. G., Howland, K. C., Abbas, A. K. & Weiss, A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines. Nature Immunol. 2, 37–44 (2001). Overexpression of Akt results in increased IL2 promoter activity in Jurkat cells and enhanced IL-2 and IFN-γ production in retrovirally-transduced CD28-deficient T cells, indicating that Akt activity mimics CD28-mediated T-cell signalling.
  CAS Google Scholar
• Miron, M. et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nature Cell Biol. 3, 596–601 (2001).
  CAS PubMed Google Scholar
• Holdorf, A. D. et al. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190, 375–384 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kim, H. H., Tharayil, M. & Rudd, C. E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273, 296–301 (1998).
  CAS PubMed Google Scholar
• Schneider, H., Prasad, K. V., Shoelson, S. E. & Rudd, C. E. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181, 351–355 (1995).
  CAS PubMed Google Scholar
• Damle, N. K., Doyle, L. V., Grosmaire, L. S. & Ledbetter, J. A. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J. Immunol. 140, 1753–1761 (1988).
  CAS PubMed Google Scholar
• Brunet, J. F. et al. A new member of the immunoglobulin superfamily CTLA-4. Nature 328, 267–270 (1987).
  CAS PubMed Google Scholar
• Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).
  CAS PubMed PubMed Central Google Scholar
• Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
  CAS PubMed PubMed Central Google Scholar
• Latchman, Y. et al. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nature Immunol. 2, 261–268 (2001).
  CAS Google Scholar
• Huard, B. & Karlsson, L. KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement. Nature 403, 325–328 (2000).
  CAS PubMed Google Scholar
• Ostrov, D. A., Shi, W., Schwartz, J. C., Almo, S. C. & Nathenson, S. G. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 290, 816–819 (2000).
  CAS PubMed Google Scholar
• Stamper, C. C. et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410, 608–611 (2001). Demonstration of the stable lattice between CTLA-4 and CD80.
  CAS PubMed Google Scholar
• Schwartz, J. C., Zhang, X., Fedorov, A. A., Nathenson, S. G. & Almo, S. C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410, 604–608 (2001). Demonstration of the stable lattice between CTLA-4 and CD86.
  CAS PubMed Google Scholar
• Zhang, Y. & Allison, J. P. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl Acad. Sci. USA 94, 9273–9278 (1997).
  CAS PubMed PubMed Central Google Scholar
• Chuang, E. et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144–151 (1997).
  CAS PubMed Google Scholar
• Shiratori, T. et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6, 583–589 (1997).
  CAS PubMed Google Scholar
• Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459–465 (1995).
  CAS PubMed Google Scholar
• Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
  CAS PubMed Google Scholar
• Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541–547 (1995).
  CAS PubMed Google Scholar
• Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985–988 (1995).
  CAS PubMed Google Scholar
• Waterhouse, P., Bachmann, M. F., Penninger, J. M., Ohashi, P. S. & Mak, T. W. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27, 1887–1892 (1997).
  CAS PubMed Google Scholar
• Chambers, C. A., Kuhns, M. S. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses. Proc. Natl Acad. Sci. USA 96, 8603–8608 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chambers, C. A., Sullivan, T. J., Truong, T. & Allison, J. P. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28, 3137–3143 (1998).
  CAS PubMed Google Scholar
• Chambers, C. A., Sullivan, T. J. & Allison, J. P. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 7, 885–895 (1997).
  CAS PubMed Google Scholar
• Tivol, E. A. et al. CTLA4 Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158, 5091–5094 (1997).
  CAS PubMed Google Scholar
• Mandelbrot, D. A., McAdam, A. J. & Sharpe, A. H. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189, 435–440 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gajewski, T. F., Fallarino, F., Fields, P. E., Rivas, F. & Alegre, M. L. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J. Immunol. 166, 3900–3907 (2001).
  CAS PubMed Google Scholar
• Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411–417 (1997).
  CAS PubMed Google Scholar
• Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. & Sharpe, A. H. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145–155 (2001).CTLA-4-deficient DO11.10 TCR transgenic T cells are resistant to tolerance induction by systemic injection of ovalbumin peptide in an adoptive-transfer model, indicating that CTLA-4 is necessary for induction of tolerance of CD4+ T cells in this model.
  CAS PubMed Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000). Crosslinking of CTLA-4 is shown to be required for the suppression by CD25+/CD4+ T cells of the proliferation of CD25 − /CD4+ T cells in vitro.
  CAS PubMed PubMed Central Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000). Blockade of CTLA-4 in vivo prevents the suppressor activity of CD25+/CD4+ T cells, the transfer of which normally inhibits induction of inflammatory bowel disease in Rag-deficient mice injected with CD25 − /CD4+ T cells, indicating that CTLA-4 is required for the regulatory activity of CD25+/CD4+ T cells.
  CAS PubMed PubMed Central Google Scholar
• Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W. & Kopf, M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128–1131 (1999). CTLA-4-expressing cells prevent disease mediated by CTLA-4-deficient cells after adoptive transfer of bone marrow cells into lymphocyte-deficient recipients.
  CAS PubMed Google Scholar
• Baecher-Allan, C., Brown, J. A., Freeman, G. J. & Hafler, D. A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167, 1245–1253 (2001).
  CAS PubMed Google Scholar
• Jonuleit, H. et al. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285–1294 (2001).
  CAS PubMed PubMed Central Google Scholar
• Levings, M. K., Sangregorio, R. & Roncarolo, M. G. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295–1302 (2001).
  CAS PubMed PubMed Central Google Scholar
• Yamagiwa, S., Gray, J. D., Hashimoto, S. & Horwitz, D. A. A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 166, 7282–7289 (2001).
  CAS PubMed Google Scholar
• Frauwirth, K. A., Alegre, M. L. & Thompson, C. B. Induction of T cell anergy in the absence of CTLA-4/B7 interaction. J. Immunol. 164, 2987–2993 (2000).
  CAS PubMed Google Scholar
• Frauwirth, K. A., Alegre, M. L. & Thompson, C. B. CTLA-4 is not required for induction of CD8+ T cell anergy in vivo. J. Immunol. 167, 4936–4941 (2001).
  CAS PubMed Google Scholar
• Sotomayor, E. M., Borrello, I., Tubb, E., Allison, J. P. & Levitsky, H. I. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc. Natl Acad. Sci. USA 96, 11476–11481 (1999).
  CAS PubMed PubMed Central Google Scholar
• Tsitoura, D. C., DeKruyff, R. H., Lamb, J. R. & Umetsu, D. T. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J. Immunol. 163, 2592–2600 (1999).
  CAS PubMed Google Scholar
• Fallarino, F., Fields, P. E. & Gajewski, T. F. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188, 205–210 (1998).
  CAS PubMed PubMed Central Google Scholar
• Lin, H. et al. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188, 199–204 (1998).
  CAS PubMed PubMed Central Google Scholar
• Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L. & Thompson, C. B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164, 5319–5327 (2000).
  CAS PubMed Google Scholar
• Carreno, B. M. et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165, 1352–1356 (2000).
  CAS PubMed Google Scholar
• Bradshaw, J. D. et al. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36, 15975–15982 (1997).
  CAS PubMed Google Scholar
• Chuang, E. et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144–151 (1997).
  CAS PubMed Google Scholar
• Miyatake, S., Nakaseko, C., Umemori, H., Yamamoto, T. & Saito, T. Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Biochem. Biophys. Res. Commun. 249, 444–448 (1998).
  CAS PubMed Google Scholar
• Chikuma, S., Murakami, M., Tanaka, K. & Uede, T. Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4. J. Cell Biochem. 78, 241–250 (2000).
  CAS PubMed Google Scholar
• Chuang, E. et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 162, 1270–1277 (1999).
  CAS PubMed Google Scholar
• Nakaseko, C. et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190, 765–774 (1999).
  CAS PubMed PubMed Central Google Scholar
• Cinek, T., Sadra, A. & Imboden, J. B. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J. Immunol. 164, 5–8 (2000).
  CAS PubMed Google Scholar
• Baroja, M. L. et al. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation. J. Immunol. 164, 49–55 (2000).
  CAS PubMed Google Scholar
• Schneider, H., Prasad, K. V. S., Shoelson, S. E. & Rudd, C. E. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 181, 351–355 (1995).
  CAS PubMed Google Scholar
• Marengere, L. E. et al. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170–1173 (1996).
  CAS PubMed Google Scholar
• Schneider, H. & Rudd, C. E. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. Biochem. Biophys. Res. Commun. 269, 279–283 (2000).
  CAS PubMed Google Scholar
• Lee, K.-M. et al. Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263–2266 (1998).
  CAS PubMed Google Scholar
• Revilla Calvo, C., Amsen, D. & Kruisbeek, A. M. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 186, 1645–1653 (1997).
  Google Scholar
• Olsson, C., Riesbeck, K., Dohlsten, M., Michaelsson, E. & Riebeck, K. CTLA-4 ligation suppresses CD28-induced NF-κB and AP-1 activity in mouse T cell blasts. J. Biol. Chem. 14, 14400–14405 (1999). | PubMed |
  Google Scholar
• Fraser, J. H., Rincon, M., McCoy, K. D. & Le Gros, G. CTLA4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cells. Eur. J. Immunol. 29, 838–844 (1999).
  CAS PubMed Google Scholar
• Dong, C. et al. Defective T cell differentiation in the absence of Jnk1. Science 282, 2092–2095 (1998).
  CAS PubMed Google Scholar
• Sabapathy, K. et al. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 193, 317–328 (2001).
  CAS PubMed PubMed Central Google Scholar
• Yang, D. D. et al. Differentiation of CD4+ T cells to TH1 cells requires MAP kinase JNK2. Immunity 9, 575–585 (1998).
  CAS PubMed Google Scholar
• Sabapathy, K. et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116–125 (1999).
  CAS PubMed Google Scholar
• Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91–94 (2000).Using T cells deficient in both JNK1 and JNK2 activity, this article shows that lack of JNK function does not prevent IL-2 production or proliferation of naive T cells, but results in promotion of T H 2 cell differentiation, indicating that JNK activity normally prevents this effector function.
  CAS PubMed Google Scholar